https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/accounts-payable https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/accrued-liabilities-current https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/accrued-professional-fees-current https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/accumulated-depreciation https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/acquisitions https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/additional-paid-in-capital https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/amortization-of-financing-costs https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/asset-impairment-charges https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/available-for-sale-current https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/available-for-sale-noncurrent https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/available-for-sale-securities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/basic-shares https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/business-acquisition-pro-forma-earnings-per-share-diluted https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/capital-expenditures https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/cash-and-equivalents https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/cash-flow-breakdown https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/common-stock-value https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/comprehensive-income https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/contracts-revenue https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/current-assets https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/current-liabilities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/debt-carrying-amount https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/debt-unamortized-discount https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-finance-costs-current-net https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-income-tax-liabilities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-charitable-contribution-carryforwards https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-gross https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-other https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-compensated-absences https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-contingencies https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-liabilities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-liabilities-financing-arrangements https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/depreciation-and-amortization https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/depreciation-and-amortization-expense https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/derivative-liabilities-current https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/diluted-shares https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/employee-related-liabilities-current https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/eps https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/eps-basic https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/foreign-pretax-income https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/form-d-other https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/form-d-stocks https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/gains-losses-on-extinguishment-of-debt-before-write-off-of-deferred-debt-issuance-cost https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/general-and-administrative-expense https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/goodwill https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/goodwill-impairment-loss https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/impairment-of-investments https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/income-tax https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/increase-in-restricted-cash https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/insider-transactions-corporate-securities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/insider-transactions-other https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/insider-transactions-preferred https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/insider-transactions-stock-units https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/insider-transactions-warrants https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/interest-and-other-income https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/interest-expense https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/interest-expense-on-debt https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/interest-paid https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/interest-payable-current https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/investments-and-cash https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/level-3-liability-issues https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/level-3-liability-purchases https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/level-3-liability-settlements https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/long-term-notes-payable https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/maturities-of-shortterm-investments https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/net-cash-from https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/net-change-in-cash https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/net-income https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/number-of-operating-segments https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/operating-expenses https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/operating-income https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/operating-lease-payments-due https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/operating-leases-rent-expense-net https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/other-accrued-liabilities-current https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/other-noncurrent-assets https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/other-noncurrent-liabilities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/paid-in-kind-interest https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/payments-to-acquire-longterm-investments https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/preferred-shares-facts https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/preferred-stock-shares-authorized https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/preferred-stock-shares-issued https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/pretax-income https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/pretax-income-domestic https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/proceeds-from-convertible-debt https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/proceeds-from-notes-payable https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/property-plant-equipment https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/public-float https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/realized-gain-loss-on-marketable-securities-cost-method-investments-and-other-investments https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/repayments-of-convertible-debt https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/research-and-development https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/restructuring-charges https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/retained-earnings https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/revenue https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/revenue-from-grants https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/shareholders-equity https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/shares-authorized https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/shares-issued https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/stock-based-compensation https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/stock-split-ratio https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/total-assets https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/total-liabilities https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/unrealized-gain-loss-on-marketable-securities-cost-method-investments-and-other-investments https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/unrecognized-tax-benefits https://stock.noler.com/us/stock/tetralogic-pharmaceuticals-corp/valuation-allowance-deferred-tax-asset-change-in-amount